• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$0.27 $0.00 (-0.99%)

REAL-TIME: Last trade at

Hemispherx BioPharma, Inc.

AMEX:HEB

Jump to this page for:

Related Resources

Hemispherx Biopharma announces test of Ampligen with FluMist

4/30/2012 by Theflyonthewall.com

Hemispherx Biopharma Announces Test of Ampligen(R) With FluMist

4/30/2012 by GlobeNewswire

Hemispherx Publishes Peer-Reviewed Data on an Analysis of the Incidence and Clinical Impact of Neutralizing Antibodies (NABs) Against Recombinant Interferons Versus Natural Human Interferons (IFNs)

3/26/2012 by GlobeNewswire

Hemispherx Biopharma, Inc. to Host 2011 Year End Conference Call on Thursday, March 22, 2012

3/20/2012 by GlobeNewswire

Hemispherx Publishes Data on the Bioactivity of Ampligen(R) in Chronic Fatigue Syndrome ("CFS")

3/19/2012 by GlobeNewswire

Hemispherx Biopharma Announces Fiscal 2011 Year Results

3/14/2012 by GlobeNewswire

Hemispherx Biopharma genital warts drug OK’d in Argentina

1/26/2012 by Philadelphia Business Journal - Philadelphia PA

Hemispherx gains regulatory approval in Latin America

1/26/2012 by Theflyonthewall.com

Hemispherx Biopharma Gains Regulatory Approval in Latin America

1/26/2012 by GlobeNewswire

Hemispherx Biopharma gets U.S. patent office notification of two new patents

1/17/2012 by Theflyonthewall.com

Hemispherx Biopharma Receives U.S. Patent Office Notification of Two New Patents Granted for Alferon(R) LDO

1/17/2012 by GlobeNewswire

FDA Grants Hemispherx extension un NDA for CFS

1/11/2012 by Theflyonthewall.com

Hemispherx Biopharma (HEB) Gets Extension from FDA for CFS NDA Modification

1/11/2012 by StreetInsider.com

FDA Grants Hemispherx Biopharma Extension in Its Pending New Drug Application (NDA) for the Treatment of Chronic Fatigue Syndrome (CFS)

1/11/2012 by GlobeNewswire

Bird flu outbreak in Tibet confirmed by Chinese government, Xinhua reports

12/12/2011 by Theflyonthewall.com

Hemispherx Biopharma Gets Stockholder Approval For Increasing Authorized Shares

12/8/2011 by RTTNews

Hemispherx Biopharma's 2011 Stockholder Annual Meeting Final Results

12/8/2011 by GlobeNewswire

Hemispherx BioPharma extends shareholder vote on stocks

11/10/2011 by Philadelphia Business Journal - Philadelphia PA

Hemispherx Biopharma Announces Further Adjournment on Proposal Number 4 From the 2011 Annual Meeting of Stockholders

11/9/2011 by StockWatch

Hemispherx Biopharma Announces Further Adjournment on Proposal Number 4 From the 2011 Annual Meeting of Stockholders

11/9/2011 by GlobeNewswire

Hemispherx Biopharma Inc Reports Operating Results (10-Q)

11/9/2011 by GuruFocus

Hemispherx reports Q3 EPS (2c) vs. consensus (3c) (one analyst estimate)

11/9/2011 by Theflyonthewall.com

Hemispherx to host conference call

10/27/2011 by Theflyonthewall.com

Hemispherx Biopharma, Inc. to Host Conference Call on Chronic Fatigue Syndrome Progress Thursday, October 27, 2011

10/24/2011 by StockHouse

Hemispherx Biopharma, Inc. to Host Conference Call on Chronic Fatigue Syndrome Progress Thursday, October 27, 2011

10/24/2011 by GlobeNewswire

Hemispherx Biopharma Reports on Annual Stockholder Meeting

10/17/2011 by StockHouse

Hemispherx Biopharma Reports on Annual Stockholder Meeting

10/17/2011 by StockWatch

2011 Nobel Prize Awarded for Discovery of Innate Immunity Pathways -- Research Included Studies on Experimental Drug in Hemispherx Biopharma Portfolio

10/11/2011 by StockWatch

2011 Nobel Prize Awarded for Discovery of Innate Immunity Pathways -- Research Included Studies on Experimental Drug in Hemispherx Biopharma Portfolio

10/11/2011 by GlobeNewswire

Hemispherx Biopharma and Chronix Biomedical Present Data on a Novel Diagnostic Approach for CFS at the IACFS/ME Biennial Conference

9/26/2011 by StockHouse

Hemispherx Biopharma and Chronix Biomedical Present Data on a Novel Diagnostic Approach for CFS at the IACFS/ME Biennial Conference

9/26/2011 by GlobeNewswire

Hemispherx Biopharma's 2011 Stockholder Annual Meeting Set

9/19/2011 by StockHouse

Hemispherx Biopharma's 2011 Stockholder Annual Meeting Set

9/19/2011 by GlobeNewswire

Hemispherx Biopharma to Present at the Rodman and Renshaw 13th Annual Global Investment Conference

9/8/2011 by StockWatch

Hemispherx Biopharma to Present at the Rodman and Renshaw 13th Annual Global Investment Conference

9/8/2011 by GlobeNewswire

Hemispherx in alliance with Armada for Alferon

9/6/2011 by Theflyonthewall.com

Hemispherx Biopharma Enters Into a Strategic Alliance With Armada Health Care for Alferon N Injection(R)

9/6/2011 by GlobeNewswire

Hemispherx says breast cancer study with Ampligen commences

8/22/2011 by Theflyonthewall.com

Breast Cancer Study With Hemispherx Biopharma's Ampligen(R) Commences

8/22/2011 by GlobeNewswire

Hemispherx submits for regulatory approval of Alferon in Argentina

8/17/2011 by Theflyonthewall.com
See More Articles...